Evidence map›Paper›PMID 34938257›Full record

ArticleFrontiers in neurology2021

Heparin-Binding Growth-Associated Molecule (Pleiotrophin) Affects Sensory Signaling and Selected Motor Functions in Mouse Model of Anatomically Incomplete Cervical Spinal Cord Injury.

Natalia Kulesskaya, Dmitry Molotkov, Sonny Sliepen, Ekaterina Mugantseva, Arturo Garcia Horsman, Mikhail Paveliev, Heikki Rauvala

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Pleiotrophin/Midkine Pathway Is Dysregulated in a TDP-43Neuropathology : official journal of the Japanese Society of Neuropathology · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Natalia KulesskayaNeuroscience Center, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.
Dmitry MolotkovNeuroscience Center, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.
Sonny SliepenNeuroscience Center, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.
Ekaterina MugantsevaNeuroscience Center, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.
Arturo Garcia HorsmanReal-time Imaging Laboratory, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
Mikhail PavelievNeuroscience Center, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.
Heikki RauvalaNeuroscience Center, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.
University of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heparin-binding growth-associated molecule (pleiotrophin) is a neurite outgrowth-promoting secretory protein that lines developing fiber tracts in juvenile CNS (central nervous system). Previously, we have shown that heparin-binding growth-associated molecule (HB-GAM) reverses the CSPG (chondroitin sulfate proteoglycan) inhibition on neurite outgrowth in the culture medium of primary CNS neurons and enhances axon growth through the injured spinal cord in mice demonstrated by two-photon imaging. In this study, we have started studies on the possible role of HB-GAM in enhancing functional recovery after incomplete spinal cord injury (SCI) using cervical lateral hemisection and hemicontusion mouse models.

Indexed as

animal modelsBOLD signalHB-GAMpleiotrophinspinal cord injury

Identifiers

PMID34938257
PMCPMC8685413
OpenAlexW4200243771

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.